Pure Global AI
NCT05882747Completed

Renal Cell Carcinoma Metastases to Pancreas

The Results of Surgery for Renal Cell Carcinoma Metastases in the Pancreas
Rigshospitalet, DenmarkClinicalTrials.gov
Verified
Study focus
Disease/Condition
Surgery
Study type
Observational
Sponsor & location
Primary sponsor
Rigshospitalet, Denmark
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2011
End date
Dec 31, 2022
Enrollment
25 participants
Primary outcome

overall survival,disease free survival

Summary

Patients' outcome was studied after surgery for renal cell carcinoma. The primary outcome was
 overall survival and desease free survival. Secondary outcame was complications to surgery.

ICD-10 classifications
Other surgical proceduresSurgical procedure, unspecifiedDuring surgical operationDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05882747
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05882747 through Pure Global AI's free database. This phase not specified trial is sponsored by Rigshospitalet, Denmark and is currently Completed. The study focuses on Surgery. Target enrollment is 25 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.